Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma

NCT02131480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Uterus Leiomyosarcoma
Soft Tissue Leiomyosarcoma

Interventions

DRUG: Doxorubicin
DRUG: Trabectedin

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris